Nanomedicine News

RSS
Phase Ib GEN-1 Trial for Platinum-Resistant Ovarian Cancer to be Presented at 2015 ASCO

Phase Ib GEN-1 Trial for Platinum-Resistant Ovarian Cancer to be Presented at 2015 ASCO

ASCO Annual Meeting 2015: Dicerna to Present New Data from DCR-MYC Phase 1 Study in Patients with Solid Tumors

ASCO Annual Meeting 2015: Dicerna to Present New Data from DCR-MYC Phase 1 Study in Patients with Solid Tumors

Sanofi Exercises Option to Exclusive License to Develop Immunotherapy for Celiac Disease Treatment

Sanofi Exercises Option to Exclusive License to Develop Immunotherapy for Celiac Disease Treatment

Nanoparticles Combined with Potent Disrupter Can Help Prevent Spread of Triple-Negative Breast Cancer

Nanoparticles Combined with Potent Disrupter Can Help Prevent Spread of Triple-Negative Breast Cancer

3D Bioprinter May Help Make Synthesized Nerve Tissue Using Nanotechnology-Inspired Material

3D Bioprinter May Help Make Synthesized Nerve Tissue Using Nanotechnology-Inspired Material

Panacea Selects Goodwin Biotechnology for Nanoparticle Cancer Vaccine Stability Testing and Fill / Finish Project

Panacea Selects Goodwin Biotechnology for Nanoparticle Cancer Vaccine Stability Testing and Fill / Finish Project

Cologne University Hospital Initiates MagForce NanoTherm Therapy in Commercial Setting for Brain Cancer Treatment

Cologne University Hospital Initiates MagForce NanoTherm Therapy in Commercial Setting for Brain Cancer Treatment

BIND Therapeutics Provides Business Highlights and Financial Results for First Quarter 2015

BIND Therapeutics Provides Business Highlights and Financial Results for First Quarter 2015

Researchers Study Nanoscale Drug Vesicles to Determine Precise Dynamics of Crystallization

Researchers Study Nanoscale Drug Vesicles to Determine Precise Dynamics of Crystallization

New Commercially Viable Technique to Create Longer Custom-Designed Strands of DNA

New Commercially Viable Technique to Create Longer Custom-Designed Strands of DNA

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.